TOR controls translation initiation and early G1 progression in yeast
- PMID: 8741837
- PMCID: PMC278610
- DOI: 10.1091/mbc.7.1.25
TOR controls translation initiation and early G1 progression in yeast
Abstract
Saccharomyces cerevisiae cells treated with the immunosuppressant rapamycin or depleted for the targets of rapamycin TOR1 and TOR2 arrest growth in the early G1 phase of the cell cycle. Loss of TOR function also causes an early inhibition of translation initiation and induces several other physiological changes characteristic of starved cells entering stationary phase (G0). A G1 cyclin mRNA whose translational control is altered by substitution of the UBI4 5' leader region (UBI4 is normally translated under starvation conditions) suppresses the rapamycin-induced G1 arrest and confers starvation sensitivity. These results suggest that the block in translation initiation is a direct consequence of loss of TOR function and the cause of the G1 arrest. We propose that the TORs, two related phosphatidylinositol kinase homologues, are part of a novel signaling pathway that activates eIF-4E-dependent protein synthesis and, thereby, G1 progression in response to nutrient availability. Such a pathway may constitute a checkpoint that prevents early G1 progression and growth in the absence of nutrients.
Comment in
-
An MBoC favorite: TOR controls translation initiation and early G1 progression in yeast.Mol Biol Cell. 2012 Aug;23(16):3026. doi: 10.1091/mbc.E12-03-0189. Mol Biol Cell. 2012. PMID: 22891031 Free PMC article. No abstract available.
Similar articles
-
Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway.Mol Cell Biol. 1998 Aug;18(8):4463-70. doi: 10.1128/MCB.18.8.4463. Mol Cell Biol. 1998. PMID: 9671456 Free PMC article.
-
TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.Cell. 1995 Jul 14;82(1):121-30. doi: 10.1016/0092-8674(95)90058-6. Cell. 1995. PMID: 7606777
-
Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.Cell. 1993 May 7;73(3):585-96. doi: 10.1016/0092-8674(93)90144-f. Cell. 1993. PMID: 8387896
-
Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.Microbiol Mol Biol Rev. 2002 Dec;66(4):579-91, table of contents. doi: 10.1128/MMBR.66.4.579-591.2002. Microbiol Mol Biol Rev. 2002. PMID: 12456783 Free PMC article. Review.
-
The fission yeast TOR proteins and the rapamycin response: an unexpected tale.Curr Top Microbiol Immunol. 2004;279:85-95. doi: 10.1007/978-3-642-18930-2_6. Curr Top Microbiol Immunol. 2004. PMID: 14560953 Review.
Cited by
-
Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors.Invest New Drugs. 2015 Oct;33(5):1040-7. doi: 10.1007/s10637-015-0261-3. Epub 2015 Jun 20. Invest New Drugs. 2015. PMID: 26091915 Free PMC article. Clinical Trial.
-
Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets.Surg Neurol Int. 2013 Jun 1;4:72. doi: 10.4103/2152-7806.112822. Print 2013. Surg Neurol Int. 2013. PMID: 23776758 Free PMC article.
-
Osmotic stress signaling and osmoadaptation in yeasts.Microbiol Mol Biol Rev. 2002 Jun;66(2):300-72. doi: 10.1128/MMBR.66.2.300-372.2002. Microbiol Mol Biol Rev. 2002. PMID: 12040128 Free PMC article. Review.
-
Translational control by TOR and TAP42 through dephosphorylation of eIF2alpha kinase GCN2.Genes Dev. 2003 Apr 1;17(7):859-72. doi: 10.1101/gad.1069003. Epub 2003 Mar 21. Genes Dev. 2003. PMID: 12654728 Free PMC article.
-
Autophagy in yeast: mechanistic insights and physiological function.Microbiol Mol Biol Rev. 2001 Sep;65(3):463-79, table of contents. doi: 10.1128/MMBR.65.3.463-479.2001. Microbiol Mol Biol Rev. 2001. PMID: 11528006 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases